Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatocellular Carcinoma Resectable”

246 trials

Showing 20 of 246 results

Large-scale testing (Phase 3)Looking for participantsNCT05608213
What this trial is testing

Lenvatinib Plus I-125 Seed Brachytherapy vs. Lenvatinib for TACE-refractory HCC

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Second Affiliated Hospital of Guangzhou Medical University 187
Not applicableLooking for participantsNCT05713994
What this trial is testing

Combined HAIC, TKI/Anti-VEGF and ICIs as Conversion Therapy for Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Ze-yang Ding, MD 300
Not applicableStudy completedNCT03564405
What this trial is testing

Pilot Clinical Trial to Evaluate the UNI-DEB for Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Jeil Pharmaceutical Co., Ltd. 10
Large-scale testing (Phase 3)Not Yet RecruitingNCT06779461
What this trial is testing

A Clinical Trial Assessing the Safety and Efficacy of Biodegradable Magnesium Embolic Microspheres for Primary Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma Non-Resectable
InnoBM Pharmaceuticals Co., Ltd. 228
Testing effectiveness (Phase 2)Active Not RecruitingNCT03869034
What this trial is testing

HAIC Combined with PD-1 Inhibitor in Potentially Resectable Locally Advanced HCC

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 40
Testing effectiveness (Phase 2)Looking for participantsNCT05440864
What this trial is testing

Durvalumab and Tremelimumab in Resectable HCC

Who this might be right for
Hepatocellular Carcinoma
University Health Network, Toronto 28
Testing effectiveness (Phase 2)WithdrawnNCT06994299
What this trial is testing

A Pilot Trial of Preoperative Irradiation With the STRIDE (Single Dose of Tremelimumab With Ongoing Durvalumab) Regimen (PRISM) for Resectable/Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma (HCC)
Weill Medical College of Cornell University
Testing effectiveness (Phase 2)Study completedNCT00040898
What this trial is testing

Sho-Saiko-To Following Removal of Liver Cancer By Embolization in Treating Patients With Liver Cancer That Cannot Be Surgically Removed

Who this might be right for
Liver Cancer
Memorial Sloan Kettering Cancer Center
Not applicableUnknownNCT05609448
What this trial is testing

MRI-guided Holmium-166 Radioembolization

Who this might be right for
Primary Liver CancerNon-Resectable Hepatocellular Carcinoma
Radboud University Medical Center 15
Testing effectiveness (Phase 2)Study completedNCT04930315
What this trial is testing

SHR-1210 Combined With Apatinib Mesylate in the Perioperative Therapy for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Zhejiang University 78
Early research (Phase 1)UnknownNCT05225116
What this trial is testing

Safety and Efficacy of Lenvatinib and Anti-PD1 Antibody Combined With Radiotherapy Neoadjuvant Treatment for Resectable Hepatocellular Carcinoma With PVTT

Who this might be right for
Hepatocellular Carcinoma
Beijing Tsinghua Chang Gung Hospital 20
Not applicableLooking for participantsNCT05994859
What this trial is testing

SIRT for Potentially Resectable HCC

Who this might be right for
Hepatocellular Carcinoma
Second Affiliated Hospital of Guangzhou Medical University 35
Not applicableStudy completedNCT00081094
What this trial is testing

Positron Emission Tomography Using Carbon-11 Acetate and Fludeoxyglucose F 18 in Detecting Hepatocellular Carcinoma (Liver Cancer) in Patients With Known or Suspected Liver Cancer

Who this might be right for
Liver Cancer
Washington University School of Medicine 31
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07684040
What this trial is testing

Combination Therapy in Patients With Resectable Liver Cancer

Who this might be right for
Liver Cancer (Primary and Metastatic)
Affiliated Hospital of Guangdong Medical University 68
Early research (Phase 1)UnknownNCT03908840
What this trial is testing

Open-label Multicenter Phase 1 Study of TBI 302 as Second-Line Therapy in Patients With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Evolve Biologics 12
Testing effectiveness (Phase 2)Study completedNCT01395030
What this trial is testing

PET/CT in Diagnosing Patients With Liver Cancer Undergoing Surgical Resection

Who this might be right for
Adult Hepatocellular CarcinomaLocalized Resectable Adult Liver Carcinoma
Queen's Medical Center 64
Not applicableUnknownNCT05114148
What this trial is testing

Individualized Dosimetry for Holmium-166-radioembolization in Patients With Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma Non-resectable
UMC Utrecht 30
Testing effectiveness (Phase 2)UnknownNCT03114085
What this trial is testing

Apatinib Combined With Capecitabine Compared With Apatinib Treat Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
First Affiliated Hospital of Guangxi Medical University 170
Large-scale testing (Phase 3)Looking for participantsNCT06492395
What this trial is testing

Lenvatinib Plus DEB-TACE and HAIC vs. Lenvatinib Plus DEB-TACE for Large HCC With PVTT

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Second Affiliated Hospital of Guangzhou Medical University 178
Large-scale testing (Phase 3)Study completedNCT00870558
What this trial is testing

Iodine I 131 Ethiodized Oil in Preventing Recurrent Cancer in Patients Who Have Undergone Treatment for Liver Cancer

Who this might be right for
Liver Cancer
Hospices Civils de Lyon 120
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation